onr:"swepub:oai:lup.lub.lu.se:587f081b-164d-4e00-9ebe-55fa6fd82133"
Search: onr:"swepub:oai:lup.lub.lu.se:587f081b-164d-4e00-9ebe-55fa6fd82133" > No excess harms fro...
- 1 of 1
- Previous record
- Next record
- To hitlist
No excess harms from sustained-release morphine : A randomised placebo-controlled trial in chronic breathlessness
-
- Johnson, Miriam J. (author)
- Hull York Medical School
-
- Sbizzera, Illary (author)
- University of York
-
- Fairhurst, Caroline (author)
- University of York
- show more...
- show less...
- (creator_code:org_t)
- 2019-11-12
- 2020
- English 8 s.
- In: BMJ Supportive and Palliative Care. - : BMJ. - 2045-435X .- 2045-4368. ; 10:4, s. 421-428
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Objectives: We aimed to identify and evaluate: (1) treatment-emergent adverse events (TEAE (worse or new since baseline)) and the subgroup of severe TEAEs in a placebo-controlled 7-day randomised trial of regular, low-dose, sustained-release oral morphine for chronic breathlessness and (2) clinical characteristics associated with TEAE. Methods: Safety analysis of trial data. Adults with chronic breathlessness (modified Medical Research Council breathlessness score ≥2) due to heart or lung disease, or cancer, not on regular opioids were eligible. Symptoms associated with opioids (TEAE of special interest) were systematically sought using Common Terminology Criteria for Adverse Events (CTCAE) grading. Other harms could be reported at any time. The relationship between characteristics and presence of ≥1 TEAE of special interest was explored using univariable logistic regression analyses. Results: 1449/5624 (26%) Adverse Events from 279 participants were TEAE of which 150/1449 (10%) were severe (CTCAE grades 3-5). 1086/5624 (75%) were events of special interest of which 41/1086 (4%) were severe. Compared with placebo, morphine was not associated with more TEAE or severe TEAE of special interest (TEAE: OR 0.53, 95% CI 0.21 to 1.38, p=0.20; severe TEAE: OR 0.96, 95% CI 0.27 to 3.41, p=0.95) nor with CTCAE severity grade (χ2=4.39, p=0.50). Among the 26/150 (17%) with severe TEAEs, study withdrawal was more common in the morphine arm (18/26 (69%) morphine arm; 8/26 (30%) placebo arm). None of the severe TEAEs was a respiratory harm. Conclusions: Severe morphine-associated toxicity was uncommon and not associated with study arm. Clinical consequences were minor and self-limiting.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)
Keyword
- chronic breathlessness
- dyspnea
- harms
- Morphine
- safety
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
- BMJ Supportive and Palliative Care (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Johnson, Miriam ...
- Sbizzera, Illary
- Fairhurst, Carol ...
- Fazekas, Belinda
- Agar, Meera
- Ekstrom, Magnus
- show more...
- Currow, David C.
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Respiratory Medi ...
- Articles in the publication
- BMJ Supportive a ...
- By the university
- Lund University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
